about
Targeting the epigenome in malignant pleural mesotheliomaKDM4C Activity Modulates Cell Proliferation and Chromosome Segregation in Triple-Negative Breast Cancer.Phosphorylation of LSD1 by PLK1 promotes its chromatin release during mitosis.Metabolic Signaling to Chromatin.Epigenetic Determinants of Cancer.The molecular hallmarks of epigenetic control.Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to TherapyLysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer.DNA methylation in the central and efferent limbs of the chemo reflex requires carotid body neural activity.Neprosin, a Selective Prolyl Endoprotease for Bottom-up Proteomics and Histone Mapping.let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery.4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation.Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.Replication-Coupled Nucleosome Assembly in the Passage of Epigenetic Information and Cell Identity.re-TAMD: exploring interactions between H3 peptide and YEATS domain using enhanced sampling.Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts.Genetics and biology of prostate cancer
P2860
Q33890546-00279B94-D4E3-4A0A-8F1C-ABF97313BFE2Q37391872-8A42AD6E-C9F3-4599-AF56-4AE14C053DFBQ37719701-0E34AAC0-3267-46EB-96C6-54B7CFFF3EA7Q38613938-0337A190-2CD4-46C3-83F4-D7D7899E9A88Q38837858-57CE547B-2922-49D0-963F-4CB3521E74FDQ38877902-CC14F519-4780-4F55-9BCA-8887FDA9CD4DQ38975402-A1AFDEFF-E78B-475E-8926-54EB552E650DQ39433158-00B70454-AB37-4125-BD6F-0BC13E6B44D5Q41701650-71A42D6E-9FE5-4BF0-890A-BE617FF21EFCQ46259726-1BA17C12-9208-4869-90C0-CC2895B0A02FQ46267307-9BD21D5B-F75D-400F-ACDF-3CADBB1D5A92Q47134084-69FCBF1E-C7E3-4C48-AB9C-9BCEBE7954C4Q50280122-48C7181F-AD7E-4567-A73F-B52A849CAA8EQ51415557-790F2A7D-C5CB-4010-8640-63B7FC79365AQ52733069-87886E02-8130-4ADF-B8E6-4950A816BCBDQ54935970-BEF563C7-9ED4-46CE-9D4E-C17D68329C88Q55260595-26A51904-7297-4E87-BC72-71B12853B607Q57106917-807807D3-1A95-47ED-99E8-15D94B54D650
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Histone Modifications and Cancer.
@en
type
label
Histone Modifications and Cancer.
@en
prefLabel
Histone Modifications and Cancer.
@en
P2860
P1476
Histone Modifications and Cancer.
@en
P2093
James E Audia
Robert M Campbell
P2860
P304
P356
10.1101/CSHPERSPECT.A019521
P577
2016-04-01T00:00:00Z